Comparison of different measures of urinary protein excretion for prediction of renal events

Journal of the American Society of Nephrology

Volumn 21, Issue 8, 2010, Pages 1355-1360

  Lambers Heerspink, Hiddo J ^a   Gansevoort, Ron T ^a   Brenner, Barry M ^b   Cooper, Mark E ^c   Parving, Hans Henrik ^d   Shahinfar, Shahnaz ^e   De Zeeuw, Dick ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d Mental Health Services CPH   (Denmark)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; LOSARTAN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL;

EID: 77955616229     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010010063     Document Type: Article

References (19)

1. de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM: Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL. Kidney Int 65: 2309-2320, 2004 (Pubitemid 38670018)
2. Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, Patel A, Cass A, Neal B, Poulter N, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Macmahon S, Chalmers J: Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 20: 1813-1821, 2009
3. van der Velde M, Halbesma N, de Charro FT, Bakker SJ, de Zeeuw D, de Jong PE, Gansevoort RT: Screening for albuminuria identifies individuals at increased renal risk. J Am Soc Nephrol 20: 852-862, 2009
4. Miller WG, Bruns DE, Hortin GL, Sandberg S, Aakre KM, McQueen MJ, Itoh Y, Lieske JC, Seccombe DW, Jones G, Bunk DM, Curhan GC, Narva AS: Current issues in measurement and reporting of urinary albumin excretion. Clin Chem 55: 24-38, 2009
5. Hansen HP, Hovind P, Jensen BR, Parving HH: Diurnal variations of glomerular filtration rate and albuminuria in diabetic nephropathy. Kidney Int 61: 163-168, 2002
6. Jermendy G, Farkas K, Nadas J, Daroczy A, Peterfai E: Practical aspects of measuring microalbuminuria in diabetic patients. Diabetes Nutr Metab 14: 195-200, 2009
7. Guy M, Borzomato JK, Newall RG, Kalra PA, Price CP. Protein and albumin-to-creatinine ratios in random urines accurately predict 24 h protein and albumin loss in patients with kidney disease. Ann Clin Biochem 46: 468-476, 2009
8. Witte EC, Lambers Heerspink HJ, de Zeeuw D, Bakker SJ, de Jong PE, Gansevoort R: First morning voids are more reliable than spot urine samples to assess microalbuminuria. J Am Soc Nephrol 20: 436-443, 2009
9. Gansevoort RT, Brinkman J, Bakker SJ, De Jong PE, de Zeeuw D: Evaluation of measures of urinary albumin excretion. Am J Epidemiol 164: 725-727, 2006
10. Fagnani F, Souchet T, Labed D, Gaugris S, Hannedouche T, Grimaldi A: Management of hypertension and screening of renal complications by GPs in diabetic type 2 patients (France-2001). Diabetes Metab 29: 58-64, 2003
11. Edge JA, Swift PG, Anderson W, Turner B: Diabetes services in the UK: Fourth national survey; are we meeting NSF standards and NICE guidelines? Arch Intern Med 90: 1005-1009, 2005
12. Aakre KM, Thue G, Subramaniam-Haavik S, Bukve T, Morris H, Muller M, Lovrencic MV, Plum I, Kallion K, Aab A, Kutt M, Gillery P, Schneider N, Horvath AR, Onody R, Oosterhuis W, Ricos C, Perich C, Nordin G, Sandberg S: Postanalytical external quality assessment of urine albumin in primary health care: an international survey. Clin Chem 54: 1630-1636, 2008
13. Oterdoom LH, Gansevoort RT, Schouten JP, de Jong PE, Gans RO, Bakker SJ: Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population. Atherosclerosis 207: 534-540, 2009
14. Ruggenenti P, Gaspari F, Perna A, Remuzzi G: Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes. BMJ 316: 504-509, 1998
15. Lambers Heerspink HJ, Brantsma AH, de Zeeuw D, Bakker SJ, de Jong PE, Gansevoort RT: Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol 168: 897-905, 2008
16. Brenner BM, Cooper ME, de Zeeuw D, Grunfeld JP, Keane WF, Kurokawa K, McGill JB, Mitch WE, Parving HH, Remuzzi G, Ribeiro AB, Schluchter MD, Snavely D, Zhang Z, Simpson R, Ramjit D, Shahinfar S: The losartan renal protection study - rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan). J Renin Angiotensin Aldosterone Syst 1: 328-335, 2000
17. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861-869, 2001
18. Easton DF, Peto J, Babiker AG: Floating absolute risk: An alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med 10: 1025-1035, 1991
19. Pencina MJ, D'Agostino RB Sr., D'Agostino RB Jr., Vasan RS: Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27: 157-172, 2008